Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Singer

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Cancers|November 27, 2025
Results of the First Folate Receptor Alpha Testing Trial by the German Quality Assurance Initiative in Pathology (QuIP<sup>®</sup>)Alexander Scheiter, Sven Mattern, Verena Gassenmaier, et al.
British Journal of Cancer|November 1, 2018
Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinomaBenjamin Goeppert, Stephanie Roessler, Marcus Renner, et al.
Hepatology (Baltimore, Md.)|May 15, 2014
Overexpression of far upstream element (FUSE) binding protein (FBP)-interacting repressor (FIR) supports growth of hepatocellular carcinomaMona Malz, Michael Bovet, Jana Samarin, et al.
The Journal of Pathology|July 17, 2015
Concomitant expression of far upstream element (FUSE) binding protein (FBP) interacting repressor (FIR) and its splice variants induce migration and invasion of non-small cell lung cancer (NSCLC) cellsBenedikt Müller, Michael Bovet, Yi Yin, et al.
Cancers|November 13, 2021
Tetraspanin 5 (TSPAN5), a Novel Gatekeeper of the Tumor Suppressor DLC1 and Myocardin-Related Transcription Factors (MRTFs), Controls HCC Growth and SenescenceLaura Schreyer, Constanze Mittermeier, Miriam J Franz, et al.
Hepatology (Baltimore, Md.)|January 8, 2019
Integrative Analysis Defines Distinct Prognostic Subgroups of Intrahepatic CholangiocarcinomaBenjamin Goeppert, Reka Toth, Stephan Singer, et al.
Cancers|December 24, 2021
The Transmembrane Receptor TIRC7 Identifies a Distinct Subset of Immune Cells with Prognostic Implications in CholangiocarcinomaThomas Albrecht, Benjamin Goeppert, Fritz Brinkmann, et al.
Hepatology (Baltimore, Md.)|February 23, 2016
PI3K/AKT/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cellsJana Samarin, Vibor Laketa, Mona Malz, et al.
Oncotarget|June 15, 2018
Platelet activation parameters and platelet-leucocyte-conjugate formation in glioblastoma multiforme patientsSascha Marx, Maximilian Splittstöhser, Frederik Kinnen, et al.
Journal of Clinical Pathology|May 15, 2024
Combined analysis of albumin in situ hybridisation and C reactive protein immunohistochemistry for the diagnosis of intrahepatic cholangiocarcinoma: towards a molecular classification paradigmThomas Albrecht, Annik Rossberg, Fabian Rose, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Cancers|November 27, 2025
Results of the First Folate Receptor Alpha Testing Trial by the German Quality Assurance Initiative in Pathology (QuIP<sup>®</sup>)Alexander Scheiter, Sven Mattern, Verena Gassenmaier, et al.
British Journal of Cancer|November 1, 2018
Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinomaBenjamin Goeppert, Stephanie Roessler, Marcus Renner, et al.
Hepatology (Baltimore, Md.)|May 15, 2014
Overexpression of far upstream element (FUSE) binding protein (FBP)-interacting repressor (FIR) supports growth of hepatocellular carcinomaMona Malz, Michael Bovet, Jana Samarin, et al.
The Journal of Pathology|July 17, 2015
Concomitant expression of far upstream element (FUSE) binding protein (FBP) interacting repressor (FIR) and its splice variants induce migration and invasion of non-small cell lung cancer (NSCLC) cellsBenedikt Müller, Michael Bovet, Yi Yin, et al.
Cancers|November 13, 2021
Tetraspanin 5 (TSPAN5), a Novel Gatekeeper of the Tumor Suppressor DLC1 and Myocardin-Related Transcription Factors (MRTFs), Controls HCC Growth and SenescenceLaura Schreyer, Constanze Mittermeier, Miriam J Franz, et al.
Hepatology (Baltimore, Md.)|January 8, 2019
Integrative Analysis Defines Distinct Prognostic Subgroups of Intrahepatic CholangiocarcinomaBenjamin Goeppert, Reka Toth, Stephan Singer, et al.
Cancers|December 24, 2021
The Transmembrane Receptor TIRC7 Identifies a Distinct Subset of Immune Cells with Prognostic Implications in CholangiocarcinomaThomas Albrecht, Benjamin Goeppert, Fritz Brinkmann, et al.
Hepatology (Baltimore, Md.)|February 23, 2016
PI3K/AKT/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cellsJana Samarin, Vibor Laketa, Mona Malz, et al.
Oncotarget|June 15, 2018
Platelet activation parameters and platelet-leucocyte-conjugate formation in glioblastoma multiforme patientsSascha Marx, Maximilian Splittstöhser, Frederik Kinnen, et al.
Journal of Clinical Pathology|May 15, 2024
Combined analysis of albumin in situ hybridisation and C reactive protein immunohistochemistry for the diagnosis of intrahepatic cholangiocarcinoma: towards a molecular classification paradigmThomas Albrecht, Annik Rossberg, Fabian Rose, et al.
Pageof 10